| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Alpha Cognition Inc.
13G
ACOG · 02074J501
|
7.4% |
9/23/2026
Event 7/14/2026
|
|||
| Manchester Management Company, LLC | 6.9% | ||||
| Manchester Management PR, LLC | 6.9% | ||||
| Manchester Explorer, L.P. | 6.1% | ||||
| James E. Besser | 7.4% | ||||
| Morgan C. Frank | 6.3% | ||||
|
Eupraxia Pharmaceuticals Inc.
13G/A
Amendment 3
EPRX · 29842P105
|
4.5% |
8/13/2026
Event 6/30/2026
|
|||
| Manchester Management Company, LLC | 4.3% | ||||
| Manchester Management PR, LLC | 4.3% | ||||
| Manchester Explorer, L.P. | 4.1% | ||||
| James E. Besser | 4.5% | ||||
| Morgan C. Frank | 4.3% | ||||
|
Alpha Cognition Inc.
13G/A
Amendment 1
ACOG · 02074J501
|
4.9% |
5/12/2026
Event 3/31/2026
|
|||
| Manchester Management Company, LLC | 4.2% | ||||
| Manchester Management PR, LLC | 4.2% | ||||
| James E. Besser | 4.9% | ||||
| Morgan C. Frank | 4.0% | ||||
|
Eupraxia Pharmaceuticals Inc.
13G/A
Amendment 2
EPRX · 29842P105
|
7.7% |
5/12/2026
Event 3/31/2026
|
|||
| Manchester Management Company, LLC | 7.4% | ||||
| Manchester Management PR, LLC | 7.4% | ||||
| Manchester Explorer, L.P. | 7.1% | ||||
| James E. Besser | 7.6% | ||||
| Morgan C. Frank | 7.7% | ||||
|
Alpha Cognition Inc.
13G
ACOG · 02074J501
|
5.1% |
2/17/2026
Event 12/30/2025
|
|||
| Manchester Management Company, LLC | 5.1% | ||||
| Manchester Management PR, LLC | 5.1% | ||||
|
Eupraxia Pharmaceuticals Inc.
13G/A
Amendment 1
EPRX · 29842P105
|
9.2% |
2/17/2026
Event 12/31/2025
|
|||
| Manchester Management Company, LLC | 8.8% | ||||
| Manchester Management PR, LLC | 8.8% | ||||
| Manchester Explorer, L.P | 8.6% | ||||
| James E. Besser | 9.1% | ||||
| Morgan C. Frank | 9.2% | ||||
|
SANUWAVE Health, Inc.
13D/A
Amendment 12
SNWV · 80303D305
|
10.8% |
12/15/2025
Event 12/11/2025
|
|||
| Manchester Management Company, LLC | 10.8% | ||||
| Manchester Management PR, LLC | 10.8% | ||||
| Manchester Explorer, L.P. | 10.1% | ||||
| James E. Besser | 10.8% | ||||
| Morgan C. Frank | 10.7% | ||||
|
SANUWAVE Health, Inc.
13D/A
Amendment 11
SNWV · 80303D305
|
11.1% |
12/10/2025
Event 12/8/2025
|
|||
| Manchester Management Co LLC | 11.1% | ||||
| Manchester Explorer, L.P. | 10.1% | ||||
| James E. Besser | 11.1% | ||||
| Morgan C. Frank | 10.7% | ||||
| Manchester Management PR, LLC | 11.1% | ||||
|
Eupraxia Pharmaceuticals Inc.
13G
EPRX · 29842P105
|
10.9% |
11/13/2025
Event 12/31/2024
|
|||
| Manchester Management Company, LLC | 10.4% | ||||
| Manchester Management PR, LLC | 10.4% | ||||
| Manchester Explorer, L.P. | 10.0% | ||||
| James E. Besser | 10.9% | ||||
| Morgan C. Frank | 10.6% | ||||
|
Modular Medical, Inc.
13D/A
Amendment 10
MODD · 60785L108
|
10.5% |
4/7/2025
Event 3/31/2025
|
|||
| Manchester Management Company, LLC | 9.3% | ||||
| Manchester Explorer, L.P. | 8.7% | ||||
| Manchester Management PR, LLC | 9.3% | ||||
| James E. Besser | 10.5% | ||||
| Morgan C. Frank | 9.6% | ||||
| JEB Partners, L.P. | 0.6% | ||||
|
Modular Medical, Inc.
13D/A
Amendment 9
MODD · 60785L108
|
10.5% |
3/24/2025
Event 3/20/2025
|
|||
| Manchester Management Company, LLC | 9.3% | ||||
| Manchester Explorer, L.P. | 8.7% | ||||
| Manchester Management PR, LLC | 9.3% | ||||
| James E. Besser | 10.5% | ||||
| Morgan C. Frank | 9.4% | ||||
| JEB Partners, L.P. | 0.6% | ||||
|
Neuroone Medical Technologies Corp
13G/A
Amendment 2
NMTC · 64130M209
|
4.9% |
2/14/2025
Event 12/31/2024
|
|||
| Manchester Explorer, L.P. | 4.1% | ||||
| Manchester Management Company, LLC | 4.6% | ||||
| Manchester Management PR, LLC | 4.6% | ||||
| James E. Besser | 4.9% | ||||
| Morgan C. Frank | 4.4% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.